Famotidine

Product NDC
67877-775
11-digit product format
678770775
Labeler code
67877
Product ID
67877-775_cec5a9cd-3305-4318-873c-89da025ae1ee
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Famotidine
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Labeler
Ascend Laboratories, LLC
Application
ANDA216400
Marketing category
ANDA
Marketing start
2023-08-24
Substance
FAMOTIDINE
Active strength
40 mg/5mL
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A216400-001FAMOTIDINEFAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A216400-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-1584e616aacf4f…
2026-08-18 06:07:402026-07A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-15caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-15011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-1531067a03dcf5…
2025-08-23 18:47 UTC2025-08A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-156a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-15fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-15b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-1503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-152680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-155bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-15d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-15d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-1579d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-15301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-151e350fbaab3a…
2024-05-31 18:47 UTC2024-05A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-158072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-156a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-151c564ffb4f44…
2023-12-20 04:57 UTC2023-12A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-15ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-15a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-159b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-15a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-153f0d92c62455…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A216400-001FAMOTIDINE40MG/5MLFOR SUSPENSION / ORALAB2023-05-15a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A216400-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A216400-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A216400-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A216400-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A216400-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A216400-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A216400-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A216400-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A216400-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A216400-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A216400-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A216400-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A216400-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A216400-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A216400-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A216400-001AB18072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A216400-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A216400-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A216400-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A216400-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A216400-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A216400-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A216400-001AB13f0d92c62455…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A216400-001AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Famotidine
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
FAMOTIDINE40 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
5QZO15J2Z8Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
310274Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
b2228be0-472b-4e47-9910-af0bf12fde77Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
396bde5c-c78e-2f8b-ab1f-2ee6ba32bcaeProduct name720260317
1e73f975-1ce7-705e-2bcf-788b1b5e24baProduct name520251124
cf645750-2e70-f6e1-c05a-a52847def5ddProduct name920250312
4fdc761c-585e-054b-8ebe-86130a26e4c1Product name220221205
fc2e1e31-353a-2c24-a4b4-fcf93bf7e38eProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67877-775-89Famotidine50 mL in 1 BOTTLEPOWDER, FOR SUSPENSION503

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
67877-775-89ML - Milliliter67877-775544dfbf0-db50-4873-801f-57c547c9494012023-09-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
67877-775FAMOTIDINE POWDER, FOR SUSPENSION [ASCEND LABORATORIES, LLC]3Current NDC, 1 package rows20230902_b2228be0-472b-4e47-9910-af0bf12fde77.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FamotidineFAMOTIDINEAscend Laboratories, LLCb2228be0-472b-4e47-9910-af0bf12fde772026-07-27Warnings, Adverse reactionsExact identifier
application applno (ANDA): 216400
application number: ANDA216400
ndc (product): 67877-775

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310274famotidine 40 MG in 5 mL Oral SuspensionPSNb2228be0-472b-4e47-9910-af0bf12fde773
310274famotidine 8 MG/ML Oral SuspensionSCDb2228be0-472b-4e47-9910-af0bf12fde773
310274famotidine 40 MG per 5 ML Oral SuspensionSYb2228be0-472b-4e47-9910-af0bf12fde773

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
67877-775-896787707758950 mL in 1 BOTTLE (67877-775-89) 50 ml2023-08-24NoNoCurrent